From Discovery to Translation: Characterization of C-Mannosyltryptophan and Pseudouridine as Markers of Kidney Function

[1]  Uwe Christians,et al.  Amino acids in a targeted versus a non-targeted metabolomics LC-MS/MS assay. Are the results consistent? , 2016, Clinical biochemistry.

[2]  J. Roy,et al.  Supplementary Material for: Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study , 2016 .

[3]  Harold I. Feldman,et al.  Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study , 2016, American Journal of Nephrology.

[4]  T. Spector,et al.  Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms , 2016, PloS one.

[5]  Christian Gieger,et al.  A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. , 2016, Journal of the American Society of Nephrology : JASN.

[6]  E. Ferrannini,et al.  Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics. , 2016, The Journal of clinical endocrinology and metabolism.

[7]  Christian Gieger,et al.  Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality , 2015, PLoS genetics.

[8]  Florian Kronenberg,et al.  Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  Thomas Kocher,et al.  1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.

[10]  T. Meyer,et al.  Uremic solutes and risk of end stage renal disease in type 2 diabetes , 2014, Kidney international.

[11]  Christian Gieger,et al.  Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  R. Vasan,et al.  A combined epidemiologic and metabolomic approach improves CKD prediction. , 2013, Journal of the American Society of Nephrology : JASN.

[13]  Kai-Uwe Eckardt,et al.  Evolving importance of kidney disease: from subspecialty to global health burden , 2013, The Lancet.

[14]  K. Suhre,et al.  Metabolomics platforms for genome wide association studies--linking the genome to the metabolome. , 2013, Current opinion in biotechnology.

[15]  C. Gieger,et al.  Serum metabolite concentrations and decreased GFR in the general population. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[17]  Rupasri Mandal,et al.  Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update , 2012, Genome Medicine.

[18]  Hans-Ulrich Prokosch,et al.  The German Chronic Kidney Disease (GCKD) study: design and methods. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[20]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[21]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[22]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[23]  H. Senn,et al.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. , 2006, Analytical chemistry.

[24]  A. Hishida,et al.  The diagnostic value of serum concentrations of 2-(α-mannopyranosyl)-L-tryptophan for normal renal function , 2004 .

[25]  A. Hishida,et al.  Tryptophan glycoconjugate as a novel marker of renal function. , 2001, The American journal of medicine.

[26]  M. Herderich,et al.  Tryptophan glycoconjugates in food and human urine. , 1999, The Biochemical journal.

[27]  W. H. Hannon,et al.  Pseudouridine is unsuitable as an endogenous renal clearance marker. , 1988, Clinical chemistry.

[28]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[29]  T. Russo,et al.  Determination of pseudouridine and other nucleosides in human blood serum by high-performance liquid chromatography. , 1983, Analytical biochemistry.

[30]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[31]  Hans-Ulrich Prokosch,et al.  Designing and implementing a biobanking IT framework for multiple research scenarios. , 2012, Studies in health technology and informatics.

[32]  M. Marcelli,et al.  Design and Methods , 2011 .

[33]  V. Spustová,et al.  Pseudouridine excretion in healthy subjects and its accumulation in renal failure. , 1992, Nephron.